Biological Dynamics collaborates on clinical utility studies to examine the impact of its early pancreatic cancer detection assay

The company partners with QURE and Curta to assess value of early identification in high-risk cohorts SAN DIEGO, Nov. 22, 2022 /PRNewswire/ — Biological Dynamics, an exosome-isolation technology and early disease detection diagnostic company, today announced that it has partnered with…

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks